SAB Biotherapeutics SABS
NASDAQ SABS
$3.11 +0.04 (+1.30%)
At close: Nov 11, 2026 · 4:00 PM EST

SAB Biotherapeutics (SABS) Change in Taxes (2022)

Updated

SAB Biotherapeutics' Change in Taxes was $92,281 in Q1 2022.

Analysis

SAB Biotherapeutics (SABS) Change in Taxes (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Taxes (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 204.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 SAB Biotherapeutics 279.79 Mn -130.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 92,281.00
API Access

SAB Biotherapeutics Change in Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-taxes&ticker=SABS&period=max&api_key=YOUR_API_KEY